BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 15207960)

  • 1. Live flavivirus vaccines: reasons for caution.
    Seligman SJ; Gould EA
    Lancet; 2004 Jun; 363(9426):2073-5. PubMed ID: 15207960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flaviviruses and flavivirus vaccines.
    Heinz FX; Stiasny K
    Vaccine; 2012 Jun; 30(29):4301-6. PubMed ID: 22682286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available.
    Ishikawa T; Yamanaka A; Konishi E
    Vaccine; 2014 Mar; 32(12):1326-37. PubMed ID: 24486372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys.
    Monath TP; Myers GA; Beck RA; Knauber M; Scappaticci K; Pullano T; Archambault WT; Catalan J; Miller C; Zhang ZX; Shin S; Pugachev K; Draper K; Levenbook IS; Guirakhoo F
    Biologicals; 2005 Sep; 33(3):131-44. PubMed ID: 15975826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in flavivirus vaccine development.
    Coller BA; Clements DE; Martyak T; Yelmene M; Thorne M; Parks DE
    IDrugs; 2010 Dec; 13(12):880-4. PubMed ID: 21154147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New developments in flavivirus vaccines with special attention to yellow fever.
    Pugachev KV; Guirakhoo F; Monath TP
    Curr Opin Infect Dis; 2005 Oct; 18(5):387-94. PubMed ID: 16148524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis.
    Lai CJ; Monath TP
    Adv Virus Res; 2003; 61():469-509. PubMed ID: 14714441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traditional and novel approaches to flavivirus vaccines.
    Pugachev KV; Guirakhoo F; Trent DW; Monath TP
    Int J Parasitol; 2003 May; 33(5-6):567-82. PubMed ID: 12782056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of flavivirus vaccines.
    Barrett AD
    Ann N Y Acad Sci; 2001 Dec; 951():262-71. PubMed ID: 11797783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines.
    Brandler S; Tangy F
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):271-91. PubMed ID: 17869338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Attenuating Mutations: Tools for a New Vaccine Design against Flaviviruses.
    Khou C; Pardigon N
    Intervirology; 2017; 60(1-2):8-18. PubMed ID: 28869941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
    Guy B; Guirakhoo F; Barban V; Higgs S; Monath TP; Lang J
    Vaccine; 2010 Jan; 28(3):632-49. PubMed ID: 19808029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research advances in plant-made flavivirus antigens.
    Martínez CA; Giulietti AM; Talou JR
    Biotechnol Adv; 2012; 30(6):1493-505. PubMed ID: 22480936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavivirus immunization with capsid-deletion mutants: basics, benefits, and barriers.
    Mandl CW
    Viral Immunol; 2004; 17(4):461-72. PubMed ID: 15671744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advancement in flavivirus vaccine development.
    Chang GJ; Kuno G; Purdy DE; Davis BS
    Expert Rev Vaccines; 2004 Apr; 3(2):199-220. PubMed ID: 15056045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Third-generation flavivirus vaccines based on single-cycle, encapsidation-defective viruses.
    Widman DG; Frolov I; Mason PW
    Adv Virus Res; 2008; 72():77-126. PubMed ID: 19081489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and biological characterization of artificial recombinants between a wild type flavivirus (Kunjin) and a live chimeric flavivirus vaccine (ChimeriVax-JE).
    Pugachev KV; Schwaiger J; Brown N; Zhang ZX; Catalan J; Mitchell FS; Ocran SW; Rumyantsev AA; Khromykh AA; Monath TP; Guirakhoo F
    Vaccine; 2007 Sep; 25(37-38):6661-71. PubMed ID: 17693000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dengue and other emerging flaviviruses.
    Solomon T; Mallewa M
    J Infect; 2001 Feb; 42(2):104-15. PubMed ID: 11531316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formalin-inactivated whole virus and recombinant subunit flavivirus vaccines.
    Eckels KH; Putnak R
    Adv Virus Res; 2003; 61():395-418. PubMed ID: 14714438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse and hamster models for the study of therapy against flavivirus infections.
    Charlier N; De Clercq E; Neyts J
    Novartis Found Symp; 2006; 277():218-29; discussion 229-32, 251-3. PubMed ID: 17319165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.